For nearly 30 years, we have been measuring serum prostatic acid phosphatase as part of our clinical staging workup of all new prostate cancer patients. PAP has a very high negative predictive value for a nuclear medicine bone scan result, so we risk stratify patients to avoid bone scans is most patients. I've attached two of our papers on the usefulness of the test.